Ingredion (INGR) Q3 2026 Earnings Call Transcript

Ingredion (INGR) reported Q3 2026 earnings below expectations, with net sales up 2% excluding the Pakistan business sale. Higher manufacturing costs and a stronger Mexican peso pressured profitability. The company lowered its full-year outlook due to slower-than-expected profit recovery at Argo and cautious consumer demand views. Texture & Healthful Solutions saw 2% net sales volume growth, while Food & Industrial Ingredients LATAM grew 4%.

Original reporting
Published Nov 5, 2026, 8:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 9:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ingredion (INGR) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$INGRBearishMed
01

Why it matters

The earnings miss and guidance cut suggest near-term downside risk, but long-term growth from clean label solutions and the Tate & Lyle deal may provide upside.

02

Market read

Earnings miss and lowered guidance are likely to depress INGR stock, while the acquisition progress may influence sector peers.

03

What to watch

New capacity additions and clean label growth could offset short-term profit pressure.

Relevance 7/10Novelty 8/10Timing: after-hours release

Background

Ingredion reported Q3 2026 results, missing expectations and lowering its full-year outlook while discussing cost pressures and the ongoing Tate & Lyle acquisition.

Company-level read

Ticker impact

$INGRBearishHigh confidence
Context

Q3 2026 earnings call disclosed lower full-year outlook and higher costs, impacting profitability.

Expected impact

likely downward pressure as market prices in weaker outlook

Evidence & confidence

Earnings miss and lowered guidance are fresh material that typically trigger sell pressure.

Market effects

Food ingredients sector may face margin pressure from higher input costs.

Latin America operations see currency headwinds; U.S./Canada volumes decline.

Tate & Lyle acquisition progress may affect broader specialty ingredients market.

Counterpoint

If cost controls improve faster than expected, the stock could rebound on margin recovery.

Key entities

  • Ingredion

    Food ingredients producer reporting Q3 2026 earnings.

  • Tate & Lyle

    Target of pending acquisition by Ingredion.

Related articles

$INGRMed

What Ingredion (INGR) Said on Its Q3 Earnings Call

Ingredion (INGR) reported Q3 earnings with mixed results. Texture & Healthful Solutions saw 2% volume growth but a 10% drop in operating income due to higher tapioca costs. Latin America segment faced currency impacts and earthquake disruptions. The company expects flat to low-single-digit operating income growth for the year and is progressing with its Tate & Lyle acquisition.

$INGRMed

Ingredion 3Q 2026: Revenue $1.79B, EPS $2.23 — 10-Q Summary

Ingredion reported 3Q 2026 revenue of $1.79B, down 1.3% YoY, and EPS of $2.23, down 14.6%. Net income fell 17% to $142M. Declines were attributed to lower gross profit, acquisition costs, and higher manufacturing expenses, partly offset by foreign exchange gains and higher volumes. Sales in most segments were impacted by various factors, including currency impacts and natural disasters.

$INGRMed

Ingredion Incorporated Reports Third Quarter 2026 Results

Ingredion Incorporated (INGR) reported Q3 2026 results with net sales volume growth in T&HS but a 19% decrease in operating income. Diluted EPS was $2.23 (reported) and $2.28 (adjusted), down from $2.61 and $2.75 in Q3 2025. The company lowered full-year EPS guidance due to higher input costs and softer demand. CEO Jim Zallie cited Argo's slower recovery and manufacturing cost pressures as key challenges.

$INGRHighAI 8/10

Ingredion Q3 2026: Adjusted EPS Falls to $2.28 as Operating Income Drops 19%

Ingredion reported Q3 2026 net sales of $1.79B, down 1% YoY, with operating income falling 19% to $201M. Adjusted EPS dropped to $2.28 from $2.75. The company revised its full-year adjusted EPS guidance to $9.25–$9.70. Sales volume grew in Texture & Healthful Solutions, while Food & Industrial Ingredients faced challenges. Ingredion is integrating its Tate & Lyle acquisition and focusing on cost management.